Pentobarbital decreases effects of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Coadministration of CYP3A4 inducers may decrease sufentanil ranges and efficacy, probably precipitating withdrawal syndrome in sufferers which have produced physical dependence to sufentanil. Discontinuation of concomitantly used CYP3A4 inducers ma... https://zandersdnvd.review-blogger.com/44197388/top-guidelines-of-sodium-pentobarbital-for-dogs